COVID-19: Advice for residents of Noord-Brabant RIVM advises residents of the province of Noord-Brabant to limit their social contacts if they have a cold, cough or a fever. This means: stay at home.
Patient with novel coronavirus deceased An 86-year-old man who was hospitalised in the Ikazia hospital Rotterdam with COVID-19 has died. The source of infection of the patient remains unknown.
Eight new patients, Maasstad Hospital closes ICU department To date, Monday 2 March, eight new patients have been reported to RIVM. This brings the total number of positive tests in the Netherlands to 18.
Three new patients with novel coronavirus (COVID-19) Three new patients were diagnosed with the novel coronavirus (COVID-19) on March 1st, bringing the number of coronavirus patients in the Netherlands to ten.
Patient with COVID-19 in Delft On 29 February, a woman in Delft was diagnosed with the novel coronavirus (COVID-19) in the Netherlands. The woman had been in Lombardy, in Northern Italy, last week.
Air quality improved slightly in 2018 In 2018, the calculated concentrations of particulate matter (PM10 and PM2.5) and nitrogen dioxide (NO2) were below European limit values in most parts of the Netherlands. There are still a few exceedances at the local level.
Interim injunction decision Nitrogen In an interim injunction proceeding between Mesdag Zuivelfonds, Stichting Stikstofclaim and RIVM, the court has ruled that RIVM must decide on the availability and disclosure of data before 1 Janua
Two imported cases of Lassa virus in the Netherlands from Sierra Leone Two Dutch doctors working in a hospital in Sierra Leone have been infected with the Lassa virus. The doctors were probably infected during treatment of the same patient.
A pregnant woman can protect her baby against whooping cough with 22-week vaccination From 16 December 2019, pregnant women in the Netherlands will be offered the 22-week vaccination. With this vaccination, a pregnant woman protects her child and herself against whooping cough.
How to distinguish a dual user from an exclusive e-cigarette user RIVM and Maastricht University have identified a combination of factors that can be used to distinguish between exclusive e-cigarette users (vapers) on the one hand and people who smoke both regula